2-181537611-T-C

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_000885.6(ITGA4):​c.*2084T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00121 in 430,540 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0028 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00035 ( 1 hom. )

Consequence

ITGA4
NM_000885.6 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.676
Variant links:
Genes affected
ITGA4 (HGNC:6140): (integrin subunit alpha 4) The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 4 subunit. This subunit associates with a beta 1 or beta 7 subunit to form an integrin that may play a role in cell motility and migration. This integrin is a therapeutic target for the treatment of multiple sclerosis, Crohn's disease and inflammatory bowel disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
CERKL (HGNC:21699): (ceramide kinase like) This gene was initially identified as a locus (RP26) associated with an autosomal recessive form of retinitis pigmentosa (arRP) disease. This gene encodes a protein with ceramide kinase-like domains, however, the protein does not phosphorylate ceramide and its target substrate is currently unknown. This protein may be a negative regulator of apoptosis in photoreceptor cells. Mutations in this gene cause a form of retinitis pigmentosa characterized by autosomal recessive cone and rod dystrophy (arCRD). Alternative splicing of this gene results in multiple transcript variants encoding different isoforms and non-coding transcripts.[provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BS2
High AC in GnomAd4 at 422 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITGA4NM_000885.6 linkc.*2084T>C 3_prime_UTR_variant Exon 28 of 28 ENST00000397033.7 NP_000876.3 P13612-1
CERKLNM_201548.5 linkc.*573A>G 3_prime_UTR_variant Exon 13 of 13 ENST00000410087.8 NP_963842.1 Q49MI3-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITGA4ENST00000397033.7 linkc.*2084T>C 3_prime_UTR_variant Exon 28 of 28 1 NM_000885.6 ENSP00000380227.2 P13612-1
CERKLENST00000410087.8 linkc.*573A>G 3_prime_UTR_variant Exon 13 of 13 1 NM_201548.5 ENSP00000386725.3 Q49MI3-2
CERKLENST00000409440.7 linkc.*573A>G 3_prime_UTR_variant Exon 13 of 13 2 ENSP00000387080.3 Q49MI3-9
CERKLENST00000684145.1 linkc.*573A>G 3_prime_UTR_variant Exon 12 of 12 ENSP00000508396.1 G0XYE7

Frequencies

GnomAD3 genomes
AF:
0.00278
AC:
422
AN:
152058
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00954
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.000712
AC:
76
AN:
106804
AF XY:
0.000410
show subpopulations
Gnomad AFR exome
AF:
0.00911
Gnomad AMR exome
AF:
0.000991
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000484
Gnomad OTH exome
AF:
0.000904
GnomAD4 exome
AF:
0.000348
AC:
97
AN:
278364
Hom.:
1
Cov.:
0
AF XY:
0.000208
AC XY:
33
AN XY:
158888
show subpopulations
African (AFR)
AF:
0.00988
AC:
70
AN:
7084
American (AMR)
AF:
0.000925
AC:
20
AN:
21620
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
9646
East Asian (EAS)
AF:
0.00
AC:
0
AN:
9072
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54304
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
11596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
998
European-Non Finnish (NFE)
AF:
0.00000662
AC:
1
AN:
151070
Other (OTH)
AF:
0.000462
AC:
6
AN:
12974
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00277
AC:
422
AN:
152176
Hom.:
3
Cov.:
32
AF XY:
0.00266
AC XY:
198
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.00951
AC:
395
AN:
41526
American (AMR)
AF:
0.00118
AC:
18
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
67978
Other (OTH)
AF:
0.00284
AC:
6
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
21
42
64
85
106
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000898
Hom.:
0
Bravo
AF:
0.00322
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Retinitis pigmentosa Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
3.4
DANN
Benign
0.87
PhyloP100
0.68
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs188892870; hg19: chr2-182402338; API